QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as …
Over the last 12 months, insiders at QuidelOrtho Corporation have bought $349,542 and sold $446.88M worth of QuidelOrtho Corporation stock.
On average, over the past 5 years, insiders at QuidelOrtho Corporation have bought $2.49M and sold $106.1M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Blaser Brian J. (President and CEO) — $249,878. Busky Joseph M (Chief Financial Officer) — $99,663.
The last purchase of 6,033 shares for transaction amount of $249,878 was made by Blaser Brian J. (President and CEO) on 2024‑12‑11.
2024-12-11 | President and CEO | 6,033 0.009% | $41.42 | $249,878 | +3.64% | |||
2024-11-21 | Sale | 10 percent owner | 8.26M 11.5456% | $35.31 | $291.7M | +8.18% | ||
2024-08-09 | Sale | 10 percent owner | 74,134 0.11% | $41.53 | $3.08M | +0.40% | ||
2024-08-08 | Sale | 10 percent owner | 106,705 0.1577% | $41.07 | $4.38M | +0.53% | ||
2024-08-07 | Sale | 10 percent owner | 78,180 0.1173% | $39.94 | $3.12M | +5.10% | ||
2024-08-06 | Sale | 10 percent owner | 86,972 0.1299% | $40.23 | $3.5M | +3.82% | ||
2024-08-05 | Sale | 10 percent owner | 118,172 0.1748% | $40.37 | $4.77M | +2.36% | ||
2024-08-02 | Sale | 10 percent owner | 169,467 0.2536% | $42.10 | $7.13M | -1.17% | ||
2024-08-01 | Sale | 10 percent owner | 234,935 0.3468% | $41.52 | $9.75M | -1.05% | ||
2024-07-31 | Sale | 10 percent owner | 164,877 0.242% | $39.11 | $6.45M | +7.40% | ||
2024-07-30 | Sale | 10 percent owner | 150,590 0.2247% | $39.74 | $5.99M | +5.68% | ||
2024-07-29 | Sale | 10 percent owner | 158,090 0.2356% | $38.85 | $6.14M | +6.86% | ||
2024-07-26 | Sale | 10 percent owner | 103,926 0.1557% | $39.05 | $4.06M | +6.81% | ||
2024-07-25 | Sale | 10 percent owner | 406,809 0.6129% | $38.59 | $15.7M | +8.58% | ||
2024-07-24 | Sale | 10 percent owner | 214,732 0.3254% | $38.97 | $8.37M | 0.00% | ||
2024-07-23 | Sale | 10 percent owner | 99,545 0.147% | $36.52 | $3.64M | +5.14% | ||
2024-07-22 | Sale | 10 percent owner | 135,241 0.2016% | $35.31 | $4.78M | +17.18% | ||
2024-07-19 | Sale | 10 percent owner | 65,636 0.0964% | $34.12 | $2.24M | +19.34% | ||
2024-07-18 | Sale | 10 percent owner | 101,870 0.1564% | $34.13 | $3.48M | +24.62% | ||
2024-07-17 | Sale | 10 percent owner | 69,637 0.1038% | $34.81 | $2.42M | +18.65% |
Blaser Brian J. | President and CEO | 6033 0.009% | $44.84 | 1 | 0 | |
Busky Joseph M | Chief Financial Officer | 2150 0.0032% | $44.84 | 1 | 0 | |
SCHULER JACK W | 3414053 5.0762% | $44.84 | 16 | 7 | +11.81% | |
BRYANT DOUGLAS C | President & CEO | 495807 0.7372% | $44.84 | 17 | 77 | +4.66% |
Strobeck Matthew | director | 38145 0.0567% | $44.84 | 2 | 0 | <0.0001% |
The Carlyle Group | $597.34M | 18.61 | 12.46M | 0% | +$0 | 25.63 | |
T Rowe Price Investment Management Inc | $464.98M | 14.48 | 9.7M | +11.51% | +$47.99M | 0.29 | |
The Vanguard Group | $233.91M | 7.29 | 4.88M | +0.78% | +$1.81M | <0.01 | |
BlackRock | $233.23M | 7.26 | 4.87M | +1.39% | +$3.2M | 0.01 | |
Helm Capital Management LLC | $115.06M | 3.58 | 2.4M | +144.88% | +$68.07M | 3.4 |